EMC-AANL-DOX
EMC-AANL-DOX is a prodrug conjugate of Doxorubicin (DOX) activated by cysteine proteases. It exhibits antitumor activity in murine models of neuroblastoma (NB), breast cancer (4T1), fibrosarcoma (HT1080), and colorectal cancer liver metastases (CT26) . EMC-AANL-DOX is applicable for cancer research.
Product Specifications
CAS Number
1431625-66-9
Smiles
OC=1C2=C ([C@@H] (O[C@H]3C[C@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC (CCCCCN4C (=O) C=CC4=O) =O) C) =O) C) =O) CC (N) =O) =O) CC (C) C) =O) [C@H] (O) [C@H] (C) O3) C[C@@] (C (CO) =O) (O) C2) C (O) =C5C1C (=O) C=6C (C5=O) =C (OC) C=CC6
Molecular Formula
C53H67N7O19
Molecular Weight
1106.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471712-500 1x 500 µL
GP2 (Glycoprotein 2) / ZAP75 (GP2/1712), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP18088PU-N 400 µL
NKG2C (KLRC2) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 